# Azora Therapeutics, Inc. Common Stock (AZR)

> Azora Therapeutics, Inc. Common Stock (AZR) trades at $3.88 (-4.32%) as of 2:40:41 PM EST on Nov 5, 2026. Market cap is $10.63M.

Canonical: https://massive.com/quote/azr
Data as of: 2026-11-05T19:40:41.088Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$3.88** -0.17 (-4.32%)
As of 2:40:41 PM EST on Nov 5, 2026 · 15-minute delayed
Nasdaq · usd

## Stock performance

How Azora Therapeutics, Inc. Common Stock (AZR) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -3.70% |
| 1W | -20.08% |
| 1M | — |
| YTD | -20.08% |
| 1Y | -20.08% |
| 52-wk range | $3.02 – $4.97 |

From daily closes through Nov 5, 2026.

## Key statistics

Today's trading snapshot for AZR: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $3.80 – $4.04 |
| Open | $4.04 |
| Prev close | $4.05 |
| Volume | 14.29K |
| Market cap | $10.63M |
| Shares out | 2.63M |

## Insider trading

[Azora Therapeutics, Inc. Common Stock (AZR) insider trading](https://massive.com/quote/azr/insider-trading.md): open-market Form 4 buys and sells by Azora Therapeutics, Inc. Common Stock insiders over the last 12 months.

## About Azora Therapeutics, Inc. Common Stock

Azora Therapeutics Inc is a biopharmaceutical company focused on developing treatments for serious inflammatory diseases. Azora owns the royalty-free rights to its technology, which is based on the development of potential best-in-class oral agonists of the aryl hydrocarbon receptor. Azora's lead program is AT177, a proprietary colon-targeted aryl hydrocarbon receptor (AhR) agonist designed to enable localized activation with limited systemic exposure in development for ulcerative colitis.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 6 |
| Listed | Jul 27, 2018 |

[Company website](https://www.azoratherapeutics.com)

## FAQ

### What is the Azora Therapeutics, Inc. Common Stock (AZR) stock price today?

Azora Therapeutics, Inc. Common Stock (AZR) is trading at $3.88 (-4.32% on the day) as of 2:40:41 PM EST on Nov 5, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Azora Therapeutics, Inc. Common Stock?

Azora Therapeutics Inc is a biopharmaceutical company focused on developing treatments for serious inflammatory diseases. Azora owns the royalty-free rights to its technology, which is based on the development of potential best-in-class oral agonists of the aryl hydrocarbon…

### What exchange is AZR listed on?

Azora Therapeutics, Inc. Common Stock (AZR) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

## Live data

Prices here are 15-minute delayed. For real-time AZR quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=AZR`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Azora Therapeutics, Inc. Common Stock (AZR) insider trading](https://massive.com/quote/azr/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms